Valuation: Cryoport, Inc.

Capitalization 482M 411M 380M 358M 667M 44.84B 680M 4.46B 1.74B 21.53B 1.81B 1.77B 76.72B P/E ratio 2026 *
-11.9x
P/E ratio 2027 * -13.6x
Enterprise value 482M 411M 380M 358M 667M 44.84B 680M 4.46B 1.74B 21.53B 1.81B 1.77B 76.72B EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.3x
Free-Float
97.38%
Yield 2026 *
-
Yield 2027 * -
1 day-0.92%
1 week+10.26%
Current month+16.79%
1 month+25.26%
3 months-9.20%
6 months+3.98%
Current year+0.73%
1 week 9.08
Extreme 9.075
9.88
1 month 7.66
Extreme 7.66
9.88
Current year 7.61
Extreme 7.61
11.45
1 year 5.21
Extreme 5.21
11.45
3 years 4.58
Extreme 4.58
24.17
5 years 4.58
Extreme 4.58
86.3
10 years 1.5
Extreme 1.5
86.3
Manager TitleAgeSince
Chief Executive Officer 79 2012-11-04
Chief Executive Officer 61 2012-06-14
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 79 2015-09-30
Director/Board Member 61 2014-06-15
Director/Board Member 66 2015-09-24
Change 5d. change 1-year change 3-years change Capi.($)
-0.92%+10.26%+67.59%-52.29% 482M
-0.35%-0.14%+20.12%+11.21% 11.38B
-0.14%+7.62%+81.40%+44.34% 3.78B
+0.43%+0.49%-10.82% - 3.5B
-2.06%+2.46%-3.75%+21.72% 2.61B
+2.16%+3.85%-7.35%-38.83% 1.09B
-9.95%-8.59%+104.14%+5.44% 999M
-1.69%-0.48%+46.07%+126.59% 879M
+1.58%+4.75%-5.69%+49.47% 742M
+1.31%+2.26%+1.70%+33.23% 668M
Average -0.96%+3.21%+29.34%+22.32% 2.61B
Weighted average by Cap. -0.61%+3.19%+25.08%+20.33%

Financials

2026 *2027 *
Net sales 192M 163M 151M 142M 265M 17.84B 271M 1.77B 694M 8.57B 720M 705M 30.53B 210M 179M 166M 156M 290M 19.53B 296M 1.94B 760M 9.38B 788M 771M 33.42B
Net income -40.91M -34.85M -32.26M -30.37M -56.57M -3.81B -57.73M -378M -148M -1.83B -154M -150M -6.51B -36.79M -31.34M -29M -27.31M -50.86M -3.42B -51.91M -340M -133M -1.64B -138M -135M -5.85B
Net Debt - -
Logo Cryoport, Inc.
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.
Employees
688
Date Price Change Volume
26-04-10 9.670 $ -0.92% 467,438
26-04-09 9.760 $ +5.74% 471,139
26-04-08 9.230 $ +0.22% 295,863
26-04-07 9.210 $ -0.11% 340,688
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.670USD
Average target price
13.61USD
Spread / Average Target
+40.76%

Quarterly revenue - Rate of surprise